Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuweianxiao is a Traditional Chinese Medicine (TCM) formulation, primarily used in China for the treatment of gastrointestinal disorders including functional constipation, dyspepsia, and abdominal distension. Originating from Tibetan medicine, the formula typically consists of six ingredients: *Rheum palmatum* (Dahuang), *Terminalia chebula* (Hezi), *Inula helenium* (Tumu xiang), *Kaempferia galanga* (Shannai), *Calcite* (Hanyanshui), and *Sodium Bicarbonate*. It functions by promoting gastric and intestinal motility, aiding digestion, and regulating the intestinal microenvironment. Clinical research, such as trials conducted by the Second Affiliated Hospital of Nanchang University, has explored its use in treating constipation specifically associated with Parkinson's disease, investigating its impact on the gut-brain axis and intestinal flora composition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liuweianxiao (The Second Affiliated Hospital of Nanchang University).